No relationship between socioeconomic status, education level and development and progression of diabetic retinopathy in type 2 diabetes: a FIELD trial substudy.
fenofibrate
retinopathy
socioeconomic status
type 2 diabetes
Journal
Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
13
05
2023
accepted:
16
09
2023
medline:
27
11
2023
pubmed:
24
11
2023
entrez:
24
11
2023
Statut:
ppublish
Résumé
In 6002 Australian adults with type 2 diabetes and a median 5-year follow-up in the FIELD (Fenofibrate Intervention and Event Lowering in Diabetes) trial, baseline socioeconomic status (SES) and self-reported education level were not related to development of on-trial sight-threatening diabetic retinopathy. Similarly, in a retinal photography substudy (n = 549), two-step diabetic retinopathy progression was not related to SES or education.
Substances chimiques
Fenofibrate
U202363UOS
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2128-2131Subventions
Organisme : National Health and Medical Research Council, Program Grant
ID : 1150467
Informations de copyright
© 2023 Royal Australasian College of Physicians.
Références
Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003; 26: 1731-1737.
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35: 556-564.
Low L, Law JP, Hodson J, McAlpine R, O'Colmain U, MacEwen C. Impact of socioeconomic deprivation on the development of diabetic retinopathy: a population-based, cross-sectional and longitudinal study over 12 years. BMJ Open 2015; 5: e007290.
Scanlon PH, Carter SC, Foy C, Husband RF, Abbas J, Bachmann MO. Diabetic retinopathy and socioeconomic deprivation in Gloucestershire. J Med Screen 2008; 15: 118-121.
Emoto N, Okajima F, Sugihara H, Goto R. A socioeconomic and behavioral survey of patients with difficult-to-control type 2 diabetes mellitus reveals an association between diabetic retinopathy and educational attainment. Patient Prefer Adherence 2016; 10: 2151-2162.
Foreman J, Keel S, van Wijngaarden P, Crowston J, Taylor HR. The National Eye Health Survey 2016. Melbourne: Centre for Eye Research Australia and Vision 2000 Australia; 2016.
Health Across Socioeconomic Groups. Australian Institute of Health and Welfare; 2022.
Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366: 1849-1861.
Keech AC, Mitchell P, Summanen PA, O'Day J, Davis TM, Moffitt MS et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007; 370: 1687-1697.
Census of Population and Housing: Socio-Economic Indexes for Areas: Australian Bureau of Statistics; 2011. Available from URL: https://www.abs.gov.au/websitedbs/censushome.nsf/home/seifapast?opendocument&navpos=260
Klein R, Klein BE, Jensen SC, Moss SE. The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision. Ophthalmology 1994; 101: 68-76.
Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M et al. The Australian diabetes, obesity and lifestyle study (AusDiab) - methods and response rates. Diabetes Res Clin Pract 2002; 57: 119-129.
Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol 2018; 6: 69-80.
Rodriguez-Poncelas A, Mundet-Tuduri X, Miravet-Jimenez S, Casellas A, Barrot-De la Puente JF, Franch-Nadal J et al. Chronic kidney disease and diabetic retinopathy in patients with type 2 diabetes. PLoS One 2016; 11: e0149448.
van Hecke MV, Dekker JM, Stehouwer CD, Polak BC, Fuller JH, Sjolie AK et al. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 2005; 28: 1383-1389.
National Health and Medical Research Council. Clinical Guidelines for the Management of Diabetic Retinopathy. Canberra, ACT, Australia; 2008.
Chew EY, Davis MD, Danis RP, Lovato JF, Perdue LH, Greven C et al. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology 2014; 121: 2443-2451.
Australian Public Assessment Report for fenofibrate: Therapeutic Goods Administration; 2014. Available from URL: https://www.tga.gov.au/sites/default/files/auspar-fenofibrate-141208.pdf
Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC et al. Guidelines on diabetic eye care: the International Council of Ophthalmology Recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology 2018; 125: 1608-1622.
The Royal Australian College of General Practitioners. Management of Type 2 Diabetes: A Handbook for General Practice. East Melbourne, VIC: The Royal Australian College of General Practitioners; 2020.